SEC Form 4 · accession 0001225208-18-015063
Merck & Co., Inc. · MRK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James H Scholefield
Officer — EVP,Chief Info&Digital Officer
Period of report
Oct 30, 2018
Accepted (ET)
Nov 1, 2018 · 5:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000310158
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitF1,F2 | — | Oct 30, 2018 | A | 34,308 | A | Oct 30, 2019 | Oct 30, 2021 | Common Stock | 34,308 | 34,308 | D |
| Stock Option (right to buy)F3 | $72.87 | Oct 30, 2018 | A | 47,456 | A | Oct 30, 2019 | Oct 29, 2028 | Common Stock | 47,456 | 47,456 | D |
Explanation of responses
- F1Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
- F2These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 10/30/2019, 10/30/2020 and 10/30/2021.
- F3The option vests and becomes exercisable in three equal installments on 10/30/2019, 10/30/2020 and 10/30/2021.